Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study

INTRODUCTION: The aim of this study was to evaluate, under real-life conditions, the safety and efficacy of tocilizumab in patients having failed anti-TNFα therapy for spondyloarthritis. METHODS: French rheumatologists and internal-medicine practitioners registered on the Club Rhumatismes et Inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lekpa, Fernando Kemta, Poulain, Cécile, Wendling, Daniel, Soubrier, Martin, De Bandt, Michel, Berthelot, Jean Marie, Gaudin, Philippe, Toussirot, Eric, Goupille, Philippe, Pham, Thao, Sellam, Jérémie, Bruckert, Rémy, Paul, Muriel, Farrenq, Valérie, Claudepierre, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446419/
https://www.ncbi.nlm.nih.gov/pubmed/22404969
http://dx.doi.org/10.1186/ar3766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446419/
https://www.ncbi.nlm.nih.gov/pubmed/22404969
http://dx.doi.org/10.1186/ar3766

Ejemplares similares